Audits trigger new concern over aging CMS antipsychotic standards
By
Kimberly Marselas
May 03, 2023
Worries over federal audits designed to monitor nursing homes for inappropriate schizophrenia diagnosing continued to mount as some providers learned they had “failed” their check-ups months into the...
Feds’ antipsychotics program fails to reduce prescriptions in assisted living
By
Alicia Lasek
Aug 23, 2022
In a federal initiative to reduce unnecessary antipsychotics prescribing, results in assisted living didn’t match the successes seen in nursing homes, a new study reveals.
Group re-assessing antipsychotic label warning
By
Kristen Fischer
Mar 22, 2024
Project PAUSE (Psychoactive Appropriate Use for Safety and Effectiveness) will hold a workshop exploring black box warnings on antipsychotic medication instructions, especially for older adults.
Providers call for broader antipsychotic exclusions to help reduce schizophrenia diagnoses
By
Kimberly Marselas
Mar 31, 2023
Providers and quality experts are questioning why the agency hasn’t done more to review its quality measure for antipsychotic drug use.